pubmed-article:2842963 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2842963 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:2842963 | lifeskim:mentions | umls-concept:C1522230 | lld:lifeskim |
pubmed-article:2842963 | lifeskim:mentions | umls-concept:C0020966 | lld:lifeskim |
pubmed-article:2842963 | lifeskim:mentions | umls-concept:C0019340 | lld:lifeskim |
pubmed-article:2842963 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:2842963 | lifeskim:mentions | umls-concept:C1637833 | lld:lifeskim |
pubmed-article:2842963 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:2842963 | pubmed:dateCreated | 1988-10-6 | lld:pubmed |
pubmed-article:2842963 | pubmed:abstractText | Specific vaccine therapy resulted in clinical improvement or stabilization of the pathological process in some patients with herpetic conjunctivitis. The vaccine exerted an immunopotentiating effect on the immune status of the subjects under study the direction of which depended upon the initial status of the parameters examined. In some cases the positive clinical effect of the vaccine therapy was accompanied by a decrease in lymphocyte sensitization to herpes simplex virus and normalization of the lymphocyte count. | lld:pubmed |
pubmed-article:2842963 | pubmed:language | rus | lld:pubmed |
pubmed-article:2842963 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2842963 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2842963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2842963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2842963 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2842963 | pubmed:issn | 0507-4088 | lld:pubmed |
pubmed-article:2842963 | pubmed:author | pubmed-author:Barinski?I... | lld:pubmed |
pubmed-article:2842963 | pubmed:author | pubmed-author:Belokrinitski... | lld:pubmed |
pubmed-article:2842963 | pubmed:author | pubmed-author:BlokhaV VVV | lld:pubmed |
pubmed-article:2842963 | pubmed:author | pubmed-author:BukovskaiaS... | lld:pubmed |
pubmed-article:2842963 | pubmed:author | pubmed-author:BelkinaI VIV | lld:pubmed |
pubmed-article:2842963 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2842963 | pubmed:volume | 33 | lld:pubmed |
pubmed-article:2842963 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2842963 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2842963 | pubmed:pagination | 212-7 | lld:pubmed |
pubmed-article:2842963 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:meshHeading | pubmed-meshheading:2842963-... | lld:pubmed |
pubmed-article:2842963 | pubmed:articleTitle | [Dynamics of cellular immunity indices in patients with ophthalmic herpes treated with a herpetic polyvaccine]. | lld:pubmed |
pubmed-article:2842963 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2842963 | pubmed:publicationType | English Abstract | lld:pubmed |